Market Cap 21.21M
Revenue (ttm) 1.93M
Net Income (ttm) -3.10M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -160.62%
Debt to Equity Ratio 0.15
Volume 4,966,800
Avg Vol 5,474,484
Day's Range N/A - N/A
Shares Out 15.83M
Stochastic %K 88%
Beta 1.11
Analysts Strong Buy
Price Target N/A

Latest News on SXTC

China SXT Pharmaceuticals, Inc. Announces Share Consolidation

Feb 21, 2025, 12:35 PM EST - 3 months ago

China SXT Pharmaceuticals, Inc. Announces Share Consolidation